Literature DB >> 7591101

Serum response of Escherichia coli strains causing dyspepsia and urinary tract infection: relation to alpha-hemolysin production and O type.

L Siegfried1, M Kmetová, V Janigová, M Sasinka, V Takácová.   

Abstract

A total of 109 alpha-hemolytic and 104 nonhemolytic Escherichia coli isolates from children with dyspepsia and urinary tract infections were investigated for resistance to the bactericidal activity of human serum. A significantly higher proportion of serum resistance was found in alpha-hemolytic E. coli isolates than in nonhemolytic isolates (P < 0.01). An association between the titer of alpha-hemolysin produced and serum resistance was found.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7591101      PMCID： PMC173650          DOI： 10.1128/iai.63.11.4543-4545.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  27 in total

1.  Bacterial capsules and interactions with complement and phagocytes.

Authors:  I S Roberts; F K Saunders; G J Boulnois
Journal:  Biochem Soc Trans       Date:  1989-06       Impact factor: 5.407

2.  Bactericidal activity of human serum against strains of Klebsiella from different sources.

Authors:  G R Benge
Journal:  J Med Microbiol       Date:  1988-09       Impact factor: 2.472

Review 3.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.

Authors:  I Ofek; N Sharon
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

Review 4.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

5.  Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. Correlation with an LPS variation phenomenon.

Authors:  G Stawski; L Nielsen; F Orskov; I Orskov
Journal:  APMIS       Date:  1990-09       Impact factor: 3.205

Review 6.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

Authors:  W R McCabe; B Kaijser; S Olling; M Uwaydah; L A Hanson
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  A third mechanism of serum resistance in Escherichia coli.

Authors:  B S Kubens; S Nikolai; W Opferkuch
Journal:  Zentralbl Bakteriol       Date:  1989-07

10.  Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.

Authors:  A Moll; P A Manning; K N Timmis
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441
View more
  3 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

2.  Biofilm and multidrug resistance in uropathogenic Escherichia coli.

Authors:  Seema Mittal; Madhu Sharma; Uma Chaudhary
Journal:  Pathog Glob Health       Date:  2015-01-21       Impact factor: 2.894

3.  Pathogenicity of an enterotoxigenic Escherichia coli hemolysin (hlyA) mutant in gnotobiotic piglets.

Authors:  R A Moxley; E M Berberov; D H Francis; J Xing; M Moayeri; R A Welch; D R Baker; R G Barletta
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.